154195-54-7

Basic information

• Product Name: 7-(chloroacetyl)-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one
• Synonyms: 7-(chloroacetyl)-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one;2H-1-BENZAZEPIN-2-ONE, 7-(2-CHLOROACETYL)-1,3,4,5-TETRAHYDRO-;OTAVA-BB 1087088;7-(2-chloro-acetyl)-1,3,4,5-tetrahydro-benzo[b]azepin-2-one
• CAS NO: 154195-54-7
• Molecular Formula: C12H12ClNO2
• Molecular Weight: 237.685
• Mol File: 154195-54-7.mol

Chemical Properties

• Boiling Point: 475.8°C at 760 mmHg
• Flash Point: 241.5°C
• Appearance: /
• Density: 1.254g/cm³
• Vapor Pressure: 3.23E-09mmHg at 25°C
• Refractive Index: 1.561
• CAS DataBase Reference: 7-(chloroacetyl)-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 7-(chloroacetyl)-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one(154195-54-7)
• EPA Substance Registry System: 7-(chloroacetyl)-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one(154195-54-7)

Safety Data

• Hazardous Substances Data: 154195-54-7(Hazardous Substances Data)

Usage

InChI:InChI=1/C12H12ClNO2/c13-7-11(15)9-4-5-10-8(6-9)2-1-3-12(16)14-10/h4-6H,1-3,7H2,(H,14,16)

Upstream product

• 4424-80-0 2,3,4,5-tetrahydro-1H-1-benzo[b]azepin-2-one 
• 79-04-9 chloroacetyl chloride 

Relevant articles and documents

COMPOSITIONS AND METHODS OF TARGETING MUTANT K-RAS

Compounds and compositions are presented that inhibit K-ras, and especially mutant K-ras. Certain compounds preferentially or even selectively inhibit specific forms of mutant K-Ras, and particularly the G12D mutant form.

HETEROCYCLIC COMPOUNDS, PROCESS FOR PREPARATION OF THE SAME AND USE THEREOF

The present invention provides a heterocyclic compound represented by the formula (I), its stereoisomers, or a pharmaceutically acceptable salt thereof, pharmaceutical compositions thereof, and their use in preparing a medicament for the prevention and/or treatment of central nervous system disease.

N-SUBSTITUTED PIPERIDINE AND PIPERAZINE DERIVATIVES

This invention relates to compounds of the formula 1 wherein R1, R2, R7, R8, R9, U, V, Z, A, W, X, M, E, L, T and D are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system and other disorders.

Heteroaryl piperazine antipsychotic agents

Compounds of the formula STR1 and pharmaceutical compositions comprising them, wherein R1, Z, X, W and Y are as defined below. The compounds are useful in the treatment of psychosis and anxiety.